This firm's average rating is Buy from 3 analysts.
We provide trade advice to complement the prevailing
expert consensus on Apyx Medical Corp. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.
The successful prediction of Apyx Medical
stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published
stock prices of traded companies, such as Apyx Medical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at
the intrinsic value of Apyx Medical based on Apyx Medical hews, social hype, general headline patterns, and widely used
predictive technical indicators. We also calculate exposure to Apyx Medical's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Apyx Medical's related companies.
Watch out for price decline
Please consider monitoring Apyx Medical on a daily basis if you are holding a position in it. Apyx Medical is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Apyx Medical stock to be traded above the $1 level to remain listed. If Apyx Medical stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
Use Technical Analysis to project Apyx expected Price
Apyx Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Apyx Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Apyx Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...Apyx Medical Gross Profit
Apyx Medical Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Apyx Medical previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Apyx Medical Gross Profit growth over the last 10 years. Please check Apyx Medical's
gross profit and other
fundamental indicators for more details.
Details
The big decline in price over the last few months for Apyx Medical Corp could raise concerns from investors as the firm is trading at a share price of
3.11 on
172,200 in volume. The company management teams failed to add value to investors and position the firm supply of money to exploit
market volatility in
April. However, diversifying your holdings with Apyx Medical Corp or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.1. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Apyx Medical partners.
Deferred Revenue Breakdown
Apyx Medical Deferred Revenue yearly trend continues to be fairly stable with very little volatility. Deferred Revenue will likely drop to about 362.4
K in 2022. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Apyx Medical Deferred Revenue is fairly stable at the moment as compared to the past year. Apyx Medical reported Deferred Revenue of 364,500 in 2021
| 2010 | 405,000 |
| 2021 | 364,500 |
| 2022 | 362,368 |
Will Apyx Medical instantly start a turnaround?
Current potential upside is at 6.9. Apyx Medical Corp is displaying above-average volatility over the selected time horizon. Investors should scrutinize Apyx Medical Corp independently to ensure intended market timing strategies are aligned with expectations about Apyx Medical volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Apyx Medical's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Apyx Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Apyx Medical Implied Volatility
Apyx Medical's implied volatility exposes the market's sentiment of Apyx Medical Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Apyx Medical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Apyx Medical stock will not fluctuate a lot when Apyx Medical's options are near their expiration.
While some other companies in the medical devices industry are either recovering or due for a correction, Apyx Medical may not be performing as strong as the other in terms of long-term growth potentials. With a relatively neutral outlook on the current economy, it is better to hold off any trading of Apyx Medical as the current risk-reward utility is not appealing enough. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Apyx Medical.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Apyx Medical. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
